We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
MysteryVibe creates doctor-recommended sexual health devices. The company combines research and engineering by onboarding leading doctors to design devices that address major sexual health issues such as erectile dysfunction, dryness and pain during intercourse. MysteryVibe has changed over 50,000 lives in 65 countries, witnessed $1 million worth of direct sales in 2020, and became the first sexual health startup to be featured on a BBC documentary. The company has received 20+ international awards including, the coveted Design Week Awards where its product, 'Crescendo', beat the Apple Watch. MysteryVibe has featured in media entities like Men's Health, Women's Health, The Daily Dot, and Forbes, to name a few. The company will use 25% of the investment to expand and scale its digital marketing campaign, 25% to launch two new products, 25% to expand its team, and 25% on building its inventory.

Pitch Rated

82%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £498,020
Square Root (SR) aims to shake up the adult soft drinks market with its range of high-quality, fresh-pressed, small-batch sodas that contain no concentrates or artificial flavours. SR's product line includes classics, seasonal specialities, perfect serve tonics, and alcohol-free cocktails. SR asserts that unlike other craft soft drinks firms, it fully owns the soda making process from concept to bottling. The company has sold 3 million bottles to date with its products stocked in 9 Michelin star restaurants. SR has also crowdsourced a mojito recipe, secured a listing as part of the Sainsbury’s Future Brands scheme, and created collaborative-branded tonics for high-end clients like Gymkhana and Pantechnicon. The company was the winner of 3 Great Taste awards in 2019 and adjudged 'Best Drinks Producer' at the 2015 BBC Food & Farming Awards. It will use the investment to launch into the off-trade, meet increased demand, upscale its marketing strategy, and launch its drinks in cans.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £572,128
KLORIS manufactures and sells premium Cannabidiol (CBD) wellness and beauty products. The company follows a Direct-To-Consumer (DTC) model and has garnered over 1,400 loyalty club members achieving a conversion rate of over 3.4%. KLORIS asserts that this has allowed the company to build brand loyalty and respond quickly to customer needs while maintaining high gross margins. The company has procured over 20 Stock Keeping Units (SKU), is listed in leading retailers like Boots, Selfridges, Amazon Prime, Mankind, and Lookfantastic, and has signed spa treatment partnerships with BVLGARI Spa, Cloud Twelve, and others. KLORIS has earned over 120 reviews with an 'Excellent' Trustpilot rating and was shortlisted for 'Best Wellness and Self-Care Brand' in the Sunday Times STYLE Beauty Awards 2021. The company will use 40% of the investment for PR and marketing, 35% for hiring key personnel, 16% for New Product Development (NPD), and 9% for hosting events.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £334,396
Propelair is a company that has developed the world’s lowest water-flush toilet system. The toilet uses air to propel 1.5 litres of water per flush, saving water when compared to 6-9 litres per flush for conventional toilets. The company has installed nearly 4,000 units in the UK and South Africa. They were awarded the prestigious Horizon2020 grant in 2017 to develop new innovations. It has also been featured in publications such as The Daily Telegraph, London Evening Standard, and The Times. The company will use the investment as working capital and stock acquisition funds to enable growth, in the UK and South Africa and launch into other water-stressed markets like the Middle East, Australia, Hong Kong, and Singapore, and introduce its 'Smart Connected Toilet' to the market. 

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £1,236,245
Alphagreen is Europe's largest online marketplace for Cannabidiol (CBD) healthcare products listing over 150 brands and more than 2,500 products on its portal. It claims that it is backed by high-profile cannabis investors like Enexis, West Creek Investments, and others. It aspires to become the leader in the CBD market that is expected to be worth over £900 million in 2025 in the UK alone. Alphagreen aspires to build a trusted ecosystem for customers with Sleep, Pain and Anxiety problems, enable them to access alternative healthcare, and distribute medical cannabis from Q3 of 2021. The company has featured in Forbes, Business Insider, Prohibition Partners, The Financial Times, and The Grocer. It will use 31% of the investment for sales and marketing, 25% for team expansion, 16% for general corporate affairs, 15% for international expansion, and 13% for technology up-gradation.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £2,039,375
trükl is a web-based, integrated and automated parcel delivery booking platform for small businesses. The company argues that on average, 5% of all UK deliveries don’t go as planned, which amounts to over 50 million dissatisfied customer experiences. trükl intends to change this and become a contender in the parcel delivery industry that is expected to double to £21 billion by 2024. The company monitors orders for issues and alerts retailers in real-time to ensure satisfied customers across the supply chain. It has successfully monitored the delivery of 4,500+ shipments since August 2020. The company also processed 330 orders earning revenue worth £1,800 on a single day in December 2020. trükl is a member of SETsquared, an award-winning business incubator. The company will use the investment to develop its integrations further, platform features and acquire and support new retailers.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £357,477
HealthBox Software is a technology company building products for the post-COVID healthcare landscape. Its first product, ClearPass, was met with success. The tool asks an employee a series of screening questions related to COVID-19, including evidence of fever, fatigue, and dry cough, etc. ClearPass has over 400,000 end-users including companies like Johnson Controls, Remy Cointreau and the San Diego School District. HealthBox aims to be a significant contender in the global digital health market that is expected to be worth $600 billion by 2026. The company is on the verge of launching another innovative product, MyHealthBox. It is a consumer-facing digital health app that will allow users to store their medical records, easily accessible 24/7. HealthBox asserts that the app will have an array of features, including AI health assessment services, dietary advice and data-powered lifestyle guidance. The company will use 47% of the investment towards technology and development costs, and 53% towards sales and marketing.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £144,265
Lemonade Dolls (LD) is the UK's first subscription underwear brand that aims to make hassle-free and comfortable underwear for young women. The company's revenue has grown 550% since January 2020. The Lemonade Dolls brand is sold in Topshop, New Look, and ASOS Marketplace. LD has 2,600 subscribers, 15,000 Dolls on its database, and over 70,000 followers across LD and Lemon's on Instagram. It also aims to bring audiences different brands like Candy Kittens, Frank Body, Dr Paw Paw, Mooncup, and Oh K!. The company has been praised by fashion magazine Grazia as having 'Broken the mould'. The company will use the investment to develop the technology behind its subscription platform, grow its product offering, strengthen its virtual presence, and drive brand awareness.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £258,328
Fullgreen offers a range of 100% plant-based products that are low-carb and preservative-free alternatives for people looking to eat fewer carbohydrates, add more vegetables to their meals, or manage health issues such as obesity and diabetes. Fullgreen also claims that its products are shelf-stable negating the need to refrigerate. The company's catalogue includes non-Genetically Modified Organism (GMO) riced veggies, cauliflower risottos, and oat free plant-based breakfast meals, to name a few. Fullgreen points out that its products are listed in over 9,000 UK and US retailers. The company has dedicated production lines in the UK and US with a capacity of over 18 million pouches per annum. It has sold over 12 million pouches to date and earned £5.4 million in 2020. Fullgreen will use the investment to improve in-store promotions and activations, develop sampling activities for its target consumers, and boost geotargeted advertising and other digital marketing activities.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £752,246
Thalamos is a software solution for completing the Mental Health Act (MHA) forms digitally, across any device. It aims to help those with acute mental illness access care quickly reducing treatment time from 7 days to 27 hours. The company delivers SaaS (Software-as-a-Service) to National Health Service (NHS) Trusts, local authorities and private mental healthcare providers. It also works directly with the UK healthcare regulator, The Care Quality Commission (CQC). Thalamos has over £500,000 of investment raised till date. Pre Covid-19, the company was already working with the CQC and supported them in safely submitting their statutory forms to hospitals across the country. Over 75% of NHS Trusts have received Thalamos' MHA forms in the last 60 days. The company will use 48% of the investment for product development, 20% for customer on-boarding, 16% for business development, and 16% as working capital.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £290,278
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph